ArticleResearch square2026
Machine learning approaches for tuberculosis prevalence and risk factor association among high-risk groups in Kigali health facilities.
Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
Abstract
Background: Tuberculosis (TB) remains a major global health challenge, disproportionately affecting vulnerable populations in resource-limited settings. In Rwanda, the burden is high among high-risk groups including prisoners, mining workers, people living with HIV, and healthcare workers. Despite well-established national surveillance infrastructure, published evidence on applying machine learning (ML) to routinely collected electronic medical records (EMR) for identifying factors associated with TB in these populations remains limited. This study develops and compares multiple ML models to identify factors associated with TB among high-risk groups using national surveillance data from Kigali health facilities, while emphasizing careful feature engineering to avoid information leakage. Methods: We conducted a retrospective, cross-sectional analysis of 2,254 high-risk patient EMR from Rwanda Biomedical Center (RBC) surveillance systems, with TB status defined by GeneXpert results. Rigorous data cleaning and preprocessing were performed, including exclusion of records with indeterminate outcomes, removal of diagnostic and operational variables that could introduce information leakage, imputation of missing values, normalization of numerical features, and one-hot encoding of categorical variables. Multiple supervised ML models were developed and evaluated using a stratified train-test split, including logistic regression (LR), balanced random forest (BRF), gradient boosting methods (XGBoost, LightGBM, and GBM), support vector machines (SVM) with a radial basis function kernel, and an EasyEnsemble classifier. Model performance was assessed using accuracy, precision, recall, F1-score, and area under the receiver operating characteristic (ROC) curve (AUC). Results: After excluding indeterminate GeneXpert outcomes, 358 cases were retained for evaluation. Ensemble-based models showed consistently strong and stable performance, with BRF achieving the highest discrimination (AUC = 0.86), while GBM, SVM, and EasyEnsemble classifiers showed comparable performance across accuracy, precision, recall, and F1-score. Feature-importance analysis identified clinically meaningful factors, associated with TB, including site of disease, age, TB-related body mass index, HIV status, and diabetes status, indicating that the models relied on plausible biological and demographic risk factors rather than diagnostic artifacts. Conclusions: This first application of EMR-driven ML for identifying TB risk factor associations in Rwanda shows that ensemble models, combined with rigorous leakage control, achieve promising performance among high-risk populations. These tools could support national TB surveillance and screening to enhance early detection and resource allocation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.